An EU-funded project is pushing the envelope on cancer treatment delivery, through the development of emerging technology based on magnetic resonance imaging (MRI) and high-intensity focused ultrasounds (HIFU).
Researchers are combining MRI-guided HIFU with selective nano-medicine to provide a full spatial and temporal control of the drug-release process, enabling cancer treatments to be delivered exactly where they are needed, when they are needed.